Iron in neurodegenerative disorders of protein misfolding: A case of prion disorders and parkinson's disease

Keyphrases

• Alpha-synuclein (α-syn) 60%
• Alzheimer's Disease 20%
• Biochemical Processes 20%
• Brain Iron 40%
• Brain Iron Homeostasis 20%
• Brain Parenchyma 20%
• Cellular Iron 20%
• Cellular Iron Metabolism 20%
• Cellular Processes 20%
• Cerebrospinal Fluid 20%
• Conformational Change 20%
• Cytosolic Proteins 20%
• Disease-specific 20%
• Human Prions 20%
• Insoluble Aggregates 40%
• Iron Dyshomeostasis 40%
• Iron Homeostasis 20%
• Neurodegenerative Conditions 40%
• Neurodegenerative Diseases 100%
• Neurotoxicity 40%
• Normal Function 20%
• Parkinson's Disease 100%
• Prion Disorders 100%
• Prion Protein 20%
• Protein Aggregation 20%
• Protein Fragments 20%
• Protein Misfolding 100%
• PrPC 60%
• Recent Advances 20%
• Redox Signaling 20%
• Scrapie 20%
• Specificity Protein 1 20%
• Sporadic Creutzfeldt-Jakob Disease (sCJD) 80%
• Substantia Nigra 20%
• Surface Glycoprotein 20%
• Therapeutic Strategies 20%

Neuroscience

• Alzheimer's Disease 20%
• Cell Surface Protein 20%
• Iron Metabolism 20%
• Neurodegenerative Disorder 100%
• Neurotoxicity 40%
• Parenchyma 20%
• Parkinson's Disease 100%
• Prion Protein 100%
• Protein 20%
• Protein Aggregation 20%
• Protein Misfolding 100%
• Scrapie 20%
• Sporadic Creutzfeldt Jakob Disease 80%
• Substantia nigra 20%
• Synuclein 60%

Biochemistry, Genetics and Molecular Biology

• Biochemical Process 25%
• Conformational Change 25%
• Creutzfeldt-Jakob Disease 100%
• Glycoprotein 25%
• Iron Homeostasis 50%
• Iron Metabolism 25%
• Isoform 25%
• Liquid 25%
• Prevalence 25%
• Prion Protein 100%
• Protein Aggregation 25%
• Protein Misfolding 100%
• Scrapie 25%
• Synuclein 75%